Mumbai has emerged as a significant hub for pharmaceutical manufacturing , with several organizations specializing in the development of Active Pharmaceutical Ingredients (APIs). Notably, a number of leading enterprises are focused on the manufacture of Finasteride API (CAS No: 98319-26-7), meeting